David M. Brown

1973–2025 年に発表

別表記
DAVID M. BROWN · David M Brown
167
論文数
47,846
被引用数
99
h 指数
158
i10 指数

被引用数

David M. Brown の年別被引用数1952 年: 被引用 1 件1965 年: 被引用 4 件1972 年: 被引用 1 件1974 年: 被引用 1 件1975 年: 被引用 3 件1976 年: 被引用 5 件1977 年: 被引用 1 件1978 年: 被引用 7 件1979 年: 被引用 7 件1980 年: 被引用 5 件1981 年: 被引用 35 件1982 年: 被引用 24 件1983 年: 被引用 32 件1984 年: 被引用 30 件1985 年: 被引用 30 件1986 年: 被引用 41 件1987 年: 被引用 22 件1988 年: 被引用 37 件1989 年: 被引用 40 件1990 年: 被引用 23 件1991 年: 被引用 35 件1992 年: 被引用 50 件1993 年: 被引用 37 件1994 年: 被引用 38 件1995 年: 被引用 35 件1996 年: 被引用 35 件1997 年: 被引用 17 件1998 年: 被引用 30 件1999 年: 被引用 64 件2000 年: 被引用 65 件2001 年: 被引用 57 件2002 年: 被引用 58 件2003 年: 被引用 107 件2004 年: 被引用 88 件2005 年: 被引用 137 件2006 年: 被引用 170 件2007 年: 被引用 260 件2008 年: 被引用 274 件2009 年: 被引用 287 件2010 年: 被引用 303 件2011 年: 被引用 301 件2012 年: 被引用 367 件2013 年: 被引用 396 件2014 年: 被引用 393 件2015 年: 被引用 399 件2016 年: 被引用 369 件2017 年: 被引用 329 件2018 年: 被引用 264 件2019 年: 被引用 1,146 件2020 年: 被引用 1,123 件2021 年: 被引用 1,139 件2022 年: 被引用 822 件2023 年: 被引用 827 件2024 年: 被引用 1,415 件2025 年: 被引用 676 件2026 年: 被引用 27 件1953〜1964 年は被引用が無いため表示していません1966〜1971 年は被引用が無いため表示していません1973 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,055 件、この内訳の 28.2%イギリス: 引用元論文 964 件、この内訳の 8.9%中国: 引用元論文 645 件、この内訳の 6%ドイツ: 引用元論文 595 件、この内訳の 5.5%イタリア: 引用元論文 521 件、この内訳の 4.8%日本: 引用元論文 446 件、この内訳の 4.1%スイス: 引用元論文 403 件、この内訳の 3.7%オーストラリア: 引用元論文 389 件、この内訳の 3.6%フランス: 引用元論文 344 件、この内訳の 3.2%カナダ: 引用元論文 249 件、この内訳の 2.3%インド: 引用元論文 232 件、この内訳の 2.1%オランダ: 引用元論文 227 件、この内訳の 2.1%
0%28.2%その他 25.5%

分野

  • Medicine66.8%
  • Biochemistry, Genetics and Molecular Biology12%
  • Environmental Science6.9%
  • Materials Science6.3%
  • Immunology and Microbiology2.8%
  • Neuroscience1.3%
  • その他3.9%

トピック

  • Retinal Diseases and Treatments16.7%
  • Retinal Imaging and Analysis6.7%
  • Ocular Diseases and Behçet’s Syndrome5.1%
  • Ophthalmology and Visual Impairment Studies4%
  • Retinal and Optic Conditions3.3%
  • Retinal Development and Disorders2.7%
  • その他61.5%

共著者

全論文

検索で開く
  1. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Luis Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Jr. Z Bridges, Jamin Brown, David M. Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Iksoo Byon, Carlo Cagini, Jorge Calzada, Stone Cameron, Peter Campochiaro, John Carlson, Angela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih-Jen Chen, San-Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David Chow, Abosede Cole, Brian Connolly, Pierre Loic Cornut, Stephen Couvillion, Carl Danzig, Vesselin Daskalov, Amr Dessouki, Francois Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard Dreyer, Pravin Dugel, David Eichenbaum, Bora Eldem, Robert Engstrom, Joan Josep Escobar, Nicole Eter, David W. Faber, Naomi Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip Ferrone, Marta Figueroa, Howard Fine, Mitchell Fineman, Gregory M. Fox, Catherine Francais, Pablo Franco, Samantha Fraser-Bell, Nicholas Fung, Federico Furno Sola ほか 218 名 - The Lancet 2022 被引用: 686

  2. Ranibizumab for Neovascular Age-Related Macular Degeneration

    著者: , , , , , , - New England Journal of Medicine 2006 被引用: 5,866

  3. Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alexander M. Eaton, Alexander Rubowitz, Alice T. Lyon, Allen Chiang, Allen C. Ho, Allen Hu, Amir Guerami, Amr Dessouki, André Corrêa Maia de Carvalho, Andrés Emanuelli, Andrew Chang, Andrew N. Antoszyk, A Francone, Anita Prasad, Armin Wolf, Arshad M. Khanani, Ashkan M. Abbey, Asma Moulana, Barbara Wihelm, Bartosz L. Sikorski, Baruch D. Kuppermann, Benjamin Wolff, Brian Jewart, K. Brian, Brian T. Chan-Kai, Calvin E. Mein, Carel B. Hoyng, Carl C. Awh, Carl Regillio, Carlos Zeolite, Caroline R. Baumal, Catherine Creuzot‐Garcher, Catherine Français Maury, Charles C. Wykoff, Charles K Newell, Chirag Jhaveri, Chris P. Lohmann, Christiana Dinah, Colin Ma, Courtney Crawford, D Wilkin Parke, Daniel Lavinsky, Daniel B. Roth, Dante J. Pieramici, Darius M. Moshfeghi, Darrin Levin, David A. Saperstein, David M. Brown, David Gaucher, David R. Lally, David Liao, David Warren Brown, Debra A. Goldstein, Dennis M. Marcus, Derek G. Chan, Dilsher S. Dhoot, Domingo Tacite, Dominik Zalewski, Edgar M. Espana, Eleonora M. Lad, Eric H. Souied, Eric Suan, Eva Eting, Federico Furno Sola, F. De Bats, Francesco Bandello, Francisco Gómez‐Ulla, François Devin, Frank G. Holz, Fred K. Chen ほか 163 名 - The Lancet 2023 被引用: 443

  4. Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

    著者: , , , , , , , , , , , , , , , , , , , - Ophthalmology 2012 被引用: 2,470

  5. Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew Antoszyk, Luis Arias, Riaz Asaria, Marcos Avila, Carl C Awh, Joaquin Bafalluy, Carl Baker, Francesco Bandello, Mark Barakat, Karen Barraza, Gyorgy Bator, Caroline Baumal, Rubens Belfort Jr, Chris Bergstrom, George Bertolucci, Thomas Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Bordon, David Boyer, Galina Bratko, Michael Brent, Jamin Brown, David M Brown, Maria Budzinskaya, Sylvia Buffet, Stuart Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge Calzada, Peter Campochiaro, John Carlson, Alessandro Castellarin, Carlos Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred Chen, Shih-Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David Chow, Brian Connolly, Pierre Loic Cornut, Karl Csaky, Carl Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John Dickinson, Brian Do, Michael Dollin, Pravin Dugel, Jaroslava Dusova, David Eichenbaum ほか 296 名 - The Lancet 2022 被引用: 435

  6. HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration

    著者: , , , , , , , , , - Ophthalmology 2019 被引用: 911

  7. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration

    著者: , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2019 被引用: 512

  8. Vaccination induces HIV broadly neutralizing antibody precursors in humans

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Brown, David R. Ambrozak, Troy Sincomb, Xiaozhen Hu, Ryan Tingle, Erik Georgeson, Saman Eskandarzadeh, Nushin Alavi, Danny Lu, Tina-Marie Mullen, Michael Kubitz, Bettina Gröschel, Janine Maenza, Orpheus Kolokythas, Nadia J. Khati, Jeffrey M. Bethony, Shane Crotty, Mario Roederer, Gunilla B. Karlsson Hedestam, Georgia D. Tomaras, David C. Montefiori, David Diemert, Richard A. Koup, Dagna Laufer, M. Juliana McElrath, Adrian B. McDermott, William R. Schief - Science 2022 被引用: 272

  9. Ranibizumab versus Verteporfin for Neovascular Age-Related Macular Degeneration

    著者: , , , , , , , - New England Journal of Medicine 2006 被引用: 3,503

  10. Ranibizumab for Diabetic Macular Edema

    著者: , , , , , , , , , , , - Ophthalmology 2012 被引用: 1,600

  11. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul Edwards, Carl W. Baker, Michael Novák, Ricky D. Isernhagen, Todd E. Schneiderman, Lawrence S. Halperin, Michael H. Lee, David S. Boyer, Philip J. Rosenfeld, Pamela Rath, Marc H. Levy, Robert H. Rosa, John C. Hoskins, Clement K. Chan, David M. Brown, Craig M. Greven, J Michael Jumper, Linda J. Margulies, William N. Rosenthal, Richard B. Rosen, Glenn Stoller, Fadi El Baba, W. Copley McLean, Ronald Kingsley, Alice T. Lyon, Jeffrey S. Heier, Anne E. Fung, Ingrid U. Scott, John A. Wells, Michael J. Banach, Paul M. Beer, James C. Folk, Joseph I. Maguire, Srinivas R. Sadda, Richard A. Garfinkel, Judy E. Kim, Paul Berstein, Michael Rauser, Richard A. Lewis, Barron C. Fishburne, Suber Huang, Nelson R. Sabates, Nicola Kim, Robert N. Frank, Brian C. Joondeph, Odette M. Houghton, Dean P. Hainsworth, Edward Chaum, Robert H. Millay, Raymond Iezzi, Rajendra S. Apte, Ron A. Adelman, Anita Agrawal, Neelakshi Bhagat, Lawrence Ulanski, Steven D. Schwartz, Cynthia Owsley, Alan Letson, Yu-Guang He, Cynthia A. Toth, Lawrence S. Morse, Michael J. Cooney, Sandeep Grover, Henry Ferreyra, Alexander J. Brucker, David DiLoreto, Aaron Weinberg - JAMA Ophthalmology 2022 被引用: 172

  12. Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

    著者: , , , , , , , - Ophthalmology 2013 被引用: 502

  13. Faricimab Treat-and-Extend for Diabetic Macular Edema

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Suhail Alam, Arturo Alezzandrini, Virgil Alfaro, Daniel Aliseda, Arghavan Almony, Pedro Amat, Payam Amini, Andrew N. Antoszyk, Luís Arias, Riaz Asaria, Marcos Pereira de Ávila, Carl C. Awh, Joaquín Bafalluy, Carl W. Baker, Francesco Bandello, Mark Barakat, Karen Barraza, György Bátor, Caroline R. Baumal, Rubens Belfort, Chris Bergstrom, George Bertolucci, Thomas W. Bochow, Matthias Bolz, Emilia Borcz, Arnaldo Furman Bordon, David S. Boyer, Galina Bratko, Michael H. Brent, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ben Burton, Miguel Busquets, Francisco Cabrera, Carlo Cagini, Jorge I. Calzada, Peter A. Campochiaro, John S. Carlson, Alessandro Castellarin, Carlos Eduardo Cava, Voraporn Chaikitmongkol, Clement Chan, Emmanuel Chang, Jonathan S. Chang, Andrew Chang, Steve Charles, Nauman Chaudhry, Caroline Chee, Judy Chen, Fred K. Chen, Shih‐Jen Chen, Richard Cheong-Leen, Allen Chiang, Mark Chittum, David R. Chow, B. Connolly, Pierre Loïc Cornut, Karl G. Csaky, Carl J. Danzig, Arup Das, Vesselin Daskalov, Carmen Desco, Amr Dessouki, John D. Dickinson, Brian Do, Michael Dollin, Pravin U. Dugel ほか 297 名 - Ophthalmology 2023 被引用: 138

  14. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

    著者: , , , , , - Ophthalmology 2008 被引用: 1,316

  15. Venous overload choroidopathy: A hypothetical framework for central serous chorioretinopathy and allied disorders

    著者: , , , , , , , , , , , , , - Progress in Retinal and Eye Research 2021 被引用: 360

  16. TENAYA and LUCERNE

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andrew N. Antoszyk, Etelka Aradi, Luís Arias, Jennifer Arnold, Riaz Asaria, Sergei Astakhov, Yury S. Astakhov, Carl C. Awh, Chandra Balaratnasingam, Sanjiv Banerjee, Caroline R. Baumal, Matthias Becker, Rubens Belfort, Galina Bratko, William Bridges, Jamin S. Brown, David M. Brown, M V Budzinskaya, S. Buffet, Stuart C Burgess, Ik Soo Byon, Carlo Cagini, Jorge I. Calzada, Stone Cameron, Peter A. Campochiaro, John S. Carlson, Ângela Carneiro, Clement Chan, Emmanuel Chang, Andrew Chang, Daniel L. Chao, Nauman Chaudhry, Caroline Chee, Andrew Cheek, Shih‐Jen Chen, San‐Ni Chen, Gemmy Cheung, Saradha Chexal, Mark Chittum, David R. Chow, Abosede Cole, B. Connolly, Pierre Loïc Cornut, Stephen Couvillion, Carl J. Danzig, Vesselin Daskalov, Amr Dessouki, François Devin, Michael Dollin, Rosa Dolz, Louise Downey, Richard F. Dreyer, Pravin U. Dugel, David Eichenbaum, Bora Eldem, Robert E. Engstrom, Joan Josep Escobar, Nicole Eter, David Faber, Naomi S. Falk, Leonard Feiner, Alvaro Fernandez Vega, Philip J. Ferrone, Marta S. Figueroa, Howard F. Fine, Mitchell S. Fineman, Gregory M. Fox, Catherine Français, Pablo Moreno Franco, Samantha Fraser‐Bell ほか 217 名 - Ophthalmology 2024 被引用: 179

  17. Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

    著者: , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2013 被引用: 811

  18. Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study

    著者: , , , , , , , , , , , - The Lancet 2024 被引用: 119

  19. Effect of High-Dose Intravitreal Aflibercept, 8 mg, in Patients With Neovascular Age-Related Macular Degeneration

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Bridges, James W. Dooner, Wayne Solley, Andrés Emanuelli, Ronald Teed, Scott M. Friedman, Nader Moinfar, Ghassan Ghorayeb, Shelly Lee, Daniel M. Berinstein, Mitchell J. Goff, Harvey Reiser, Amir Guerami, Emily D. Ashmore, Curtis Hagedorn, Jose A. Martinez, Paul Hahn, Juner Colina-Biscotto, Vrinda Hershberger, Brian C. Joondeph, Erik Kruger, J. Shepard Bryan, Michael Lee, Mark L. Chiu, C. Nathaniel Roybal, Frank Wyant, James K. Luu, Matthew Byun, James D. Palmer, Mark R. Wieland, Joel Pearlman, Evan Berger, John D. Pitcher, Rajiv Rathod, Omar S. Punjabi, Leonard Feiner, Hema L. Ramkumar, Steven Lin, Rahul Reddy, Richard F. Dreyer, Nathan Steinle, Veeral Sheth, David Faber, Cameron Stone, Robert E. Engstrom, Robert S. Wirthlin, Mahmood El-Gasim, Robert Parnes - JAMA Ophthalmology 2023 被引用: 103

  20. Intravitreal aflibercept 8 mg in diabetic macular oedema (PHOTON): 48-week results from a randomised, double-masked, non-inferiority, phase 2/3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fareed Ali, Payam Amini, Andres Emanuelli Anzalotta, György Bátor, Ivan R. Batlle, Adam Berger, Ramanath Bhandari, William Bridges, Christian Brinkmann, Jamin S. Brown, Stuart C Burgess, Jorge I. Calzada, Antonio Capone, Dana Cervena, Steven Charles, Nauman Chaudhry, David R. Chow, W. Lloyd Clark, Paul Conrad, Matthew A. Cunningham, Hajir Dadgostar, Amr Dessouki, Dana Madison Deupree, Christopher A. Devine, David Eichenbaum, Jan Ernest, Nicolas Feltgen, M. J. Fenberg, Philip J. Ferrone, R. E. P. Frenkel, Scott M. Friedman, Julie Gasperini, Adam T. Gerstenblith, Ghassan Ghorayeb, Michel Giunta, Mitchell J. Goff, Liliya Golas, Joseph M. Googe, Jordana Fein, Curtis Hagedorn, Akira Hagiwara, Paul Hahn, Richard Hairston, Jason M. Handza, Vivienne Hau, Ken Hayashi, Jeffrey S. Heier, Vrinda Hershberger, Patrick Higgins, Yoshio Hirano, Shigeru Honda, Yasuko Ikegami, Yuichiro Ishida, Isao Ishikawa, Kiyoshi Ishii, Eric Jablon, Atul Jain, Yuichi Kaji, Kapil Kapoor, Ágnes Kerényi, Kazuhiro Kimura, Genichiro Kishino, Katalin Kiss, Takashi Kitaoka, James M. Klancnik, Namie Kobayashi, Jiro Kogo, Vladimír Korda, Erik Kruger, Sentaro Kusuhara ほか 55 名 - The Lancet 2024 被引用: 113

  21. KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

    著者: , , , , , , , , , , , , , , , , , , - American Journal of Ophthalmology 2022 被引用: 168

  22. Long-term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials

    著者: , , , , , , , , , , , , - Ophthalmology 2013 被引用: 821

  23. Intravitreal Aflibercept for Diabetic Macular Edema

    著者: , , , , , , , , , , , , , , , , , , , , , , - Ophthalmology 2014 被引用: 807

  24. Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy

    著者: , , , , , , , , , , , , , , - JAMA Ophthalmology 2021 被引用: 148